Key result
Transcatheter PFO occluder eliminates severe right AV valve regurgitation in a pediatric Fontan patient.
Why the study?
To share experience regarding difficulties encountered during percutaneous transcatheter right AV valve closure using a patent foramen ovale occluder after a Fontan procedure.
Case Report (n=1)
No
Demonstrates the feasibility of percutaneous transcatheter right AV valve closure using a PFO occluder in a pediatric patient with complex congenital heart disease following a Fontan procedure.
Hypothesis-generating for percutaneous AV valve closure in pediatric Fontan patients; larger studies needed before adoption.
In this new case study, we report a successful percutaneous transcatheter right atrioventricular (AV) valve closure procedure using a patent foramen ovale occluder (Occlutech International AB, Helsingborg, Sweden) in an 11-year-old boy who had previously undergone a Fontan procedure and surgical right AV valve closure for double-inlet left ventricle, hypoplastic right ventricle, ventricular arterial discordance and coarctation of the aorta and developed severe right AV valve regurgitation during follow-up. We aimed to share our experience regarding the difficulties encountered during the procedure.
No takes yet. Share an insight, caveat, or question.
Çaran et al. (2026) conducted a case report in Severe right atrioventricular valve regurgitation in Fontan circulation (n=1). Percutaneous transcatheter right AV valve closure using a patent foramen ovale (PFO) occluder was evaluated on Complete closure of the right AV valve with no residual leakage. Percutaneous transcatheter right atrioventricular valve closure using a patent foramen ovale occluder successfully eliminated severe regurgitation in an 11-year-old boy with Fontan circulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: